We are live on ! Find out more
ABMD

Abiomed Inc
ABMD

Delisted

ABMD was delisted on the 21st of December, 2022.

Back to rankings

527 hedge funds and large institutions have $16B invested in Abiomed Inc in 2018 Q2 according to their latest regulatory filings, with 153 funds opening new positions, 157 increasing their positions, 171 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

428% more first-time investments, than exits

New positions opened: 153 | Existing positions closed: 29

40% more funds holding in top 10

Funds holding in top 10: 15 → 21 (+6)

40% more capital invested

Capital invested by funds: $11.5B → $16B (+$4.55B)

30% more funds holding

Funds holding: 405 → 527 (+122)

8% less repeat investments, than reductions

Existing positions increased: 157 | Existing positions reduced: 171

21% less call options, than puts

Call options by funds: $167M | Put options by funds: $212M

Holders
527
Holders Change
+122
Holders Change %
+30.12%
% of All Funds
12.07%
Holding in Top 10
21
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+40%
% of All Funds
0.48%
New
153
Increased
157
Reduced
171
Closed
29
Calls
$167M
Puts
$212M
Net Calls
-$45.4M
Net Calls Change
-$39.3M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$297M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$210M
3
State Street
State Street
Massachusetts
+$158M
4
Renaissance Technologies
Renaissance Technologies
New York
+$146M
5
Two Sigma Investments
Two Sigma Investments
New York
+$138M

Top Sellers

1
BlackRock
BlackRock
New York
-$315M
2
Winslow Capital Management
Winslow Capital Management
Minnesota
-$284M
3
PAI
Palo Alto Investors
California
-$165M
4
William Blair Investment Management
William Blair Investment Management
Illinois
-$154M
5
American Century Companies
American Century Companies
Missouri
-$136M
Name Holding Trade Value Shares
Change 		Change in
Stake
M&T Bank
376
M&T Bank
New York
$523K -$27.5K -76 -6%
GP
377
Girard Partners
Pennsylvania
$518K +$459K +1,267 New
CIP
378
Chartwell Investment Partners
Pennsylvania
$516K +$457K +1,261 New
CBU
379
CIBC Bank USA
Illinois
$515K -$30.8K -85 -6%
Verition Fund Management
380
Verition Fund Management
Connecticut
$509K -$1.66M -4,581 -79%
MML Investors Services
381
MML Investors Services
Massachusetts
$505K +$112K +309 +33%
SEC
382
Seven Eight Capital
New York
$491K +$435K +1,200 New
CB
383
Commerce Bank
Missouri
$474K -$2.06M -5,675 -83%
GCA
384
Gideon Capital Advisors
New York
$466K +$413K +1,139 New
BL
385
BFSG LLC
California
$463K +$410K +1,133 New
FAAS
386
First Allied Advisory Services
California
$461K -$239K -659 -37%
MERSOM
387
Municipal Employees' Retirement System of Michigan
Michigan
$458K -$4.33M -11,950 -91%
US Bancorp
388
US Bancorp
Minnesota
$446K -$463K -1,279 -54%
CC
389
ClearArc Capital
Ohio
$445K +$394K +1,087 New
KA
390
Kovack Advisors
Florida
$440K +$122K +336 +45%
AP
391
Advisor Partners
California
$432K +$80.1K +221 +26%
CFB
392
Cullen/Frost Bankers
Texas
$425K +$376K +1,038 New
AWCI
393
Alpine Woods Capital Investors
New York
$409K – – –
CA
394
Centerpoint Advisors
Massachusetts
$409K – – –
GW
395
GW & Wade
Massachusetts
$409K – – –
AI
396
Atria Investments
North Carolina
$408K +$361K +997 New
RIM
397
Redpoint Investment Management
Australia
$391K +$347K +957 New
II
398
Ibex Investors
Colorado
$388K +$344K +949 New
AIM
399
Advantage Investment Management
Iowa
$385K – – –
CCM
400
Coldstream Capital Management
Washington
$385K +$7.61K +21 +2%
14 15
16
17 18

ABMD Hedge Fund Activity: Q2 2018 in Review

527 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q2 2018, worth a combined $16B — up 40% from $11.5B a quarter earlier.

Buyers outnumbered sellers: 153 funds opened new ABMD positions and 29 closed out — a net gain of 124 holders — while 157 added to existing stakes and 171 trimmed.

The largest buyer was Vanguard Group, adding an estimated $297M. The largest seller was BlackRock, cutting an estimated $315M.

  • 527 institutional investors held Abiomed Inc (ABMD) as of Q2 2018, up from 405 in Q1 2018.
  • Funds reported $16B of Abiomed Inc stock for Q2 2018, up 40% quarter-over-quarter.
  • 153 funds opened new Abiomed Inc positions in Q2 2018 and 29 closed out, a net change of +124 holders.
  • The largest Abiomed Inc buyer in Q2 2018 was Vanguard Group, an estimated $297M added.
  • The largest Abiomed Inc seller in Q2 2018 was BlackRock, an estimated $315M sold.

Based on aggregated 13F filings for Q2 2018.